Russell Investments Group Ltd. Purchases 27,470 Shares of LeMaitre Vascular, Inc. $LMAT

Key Points

• Russell Investments Group Ltd. increased its holdings in LeMaitre Vascular by 11.6%, owning about 1.17% of the company, worth approximately $22.17 million as of the latest SEC filing.
• LeMaitre Vascular recently reported a quarterly earnings per share (EPS) of $0.60, exceeding analyst expectations, with revenues rising 15.0% year-over-year to $63.15 million.
• The company announced a quarterly dividend of $0.20 per share, representing an annual yield of 0.8%, with a payout ratio of 38.83%.

Russell Investments Group Ltd. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 11.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 264,261 shares of the medical instruments supplier's stock after acquiring an additional 27,470 shares during the period. Russell Investments Group Ltd. owned approximately 1.17% of LeMaitre Vascular worth $22,172,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Northern Trust Corp raised its stake in LeMaitre Vascular by 5.1% during the 4th quarter. Northern Trust Corp now owns 327,815 shares of the medical instruments supplier's stock worth $30,205,000 after acquiring an additional 15,843 shares during the period. Envestnet Asset Management Inc. raised its stake in LeMaitre Vascular by 9.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 285,109 shares of the medical instruments supplier's stock worth $23,921,000 after acquiring an additional 25,680 shares during the period. Price T Rowe Associates Inc. MD raised its stake in LeMaitre Vascular by 0.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 284,779 shares of the medical instruments supplier's stock worth $26,240,000 after acquiring an additional 1,680 shares during the period. Invesco Ltd. raised its stake in LeMaitre Vascular by 34.5% during the 1st quarter. Invesco Ltd. now owns 235,436 shares of the medical instruments supplier's stock worth $19,753,000 after acquiring an additional 60,438 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in LeMaitre Vascular during the 4th quarter worth approximately $14,900,000. Institutional investors own 84.64% of the company's stock.

Insider Buying and Selling at LeMaitre Vascular

In related news, Director Bridget A. Ross sold 2,500 shares of the company's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $94.00, for a total value of $235,000.00. Following the completion of the sale, the director directly owned 2,916 shares of the company's stock, valued at $274,104. This represents a 46.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John A. Roush sold 6,561 shares of the company's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $92.55, for a total transaction of $607,220.55. Following the completion of the sale, the director directly owned 2,916 shares of the company's stock, valued at approximately $269,875.80. This trade represents a 69.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,815 shares of company stock valued at $11,280,206 in the last ninety days. 9.50% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Cantor Fitzgerald raised their target price on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 6th. Barrington Research raised shares of LeMaitre Vascular from a "market perform" rating to an "outperform" rating and set a $95.00 price objective for the company in a report on Wednesday, August 6th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $97.60.

LeMaitre Vascular Price Performance

Shares of LMAT stock traded down $0.3250 on Thursday, reaching $96.3850. The company's stock had a trading volume of 18,341 shares, compared to its average volume of 189,044. The stock's fifty day simple moving average is $85.30 and its 200-day simple moving average is $86.46. LeMaitre Vascular, Inc. has a 1 year low of $71.42 and a 1 year high of $109.58. The company has a current ratio of 13.96, a quick ratio of 11.74 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of 46.79, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The medical instruments supplier reported $0.60 EPS for the quarter, topping the consensus estimate of $0.57 by $0.03. The company had revenue of $63.15 million during the quarter, compared to analyst estimates of $62.48 million. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. LeMaitre Vascular's quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.52 earnings per share. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Analysts forecast that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 4th. Investors of record on Thursday, August 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Thursday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 0.8%. LeMaitre Vascular's dividend payout ratio is 38.83%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.